NYMOXIUM

Serial Number 98220382
606

Registration Progress

Application Filed
Oct 12, 2023
Under Examination
Sep 3, 2024
Approved for Publication
Jul 9, 2024
Published for Opposition
Jul 9, 2024
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: NYMOXIUM
Previous Owner: Nymox Pharmaceutical Corporation
Classes: 005

Trademark Image

NYMOXIUM

Basic Information

Serial Number
98220382
Filing Date
October 12, 2023
Published for Opposition
July 9, 2024
Abandonment Date
October 6, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 6, 2025
Classes
005

Rights Holder

Nymox Pharmaceutical Corporation

03
Address
Bay & Deveaux Streets
Nassau 0
BS

Ownership History

Nymox Pharmaceutical Corporation

Original Applicant
03
Nassau BS

Nymox Pharmaceutical Corporation

Owner at Publication
03
Nassau BS

Legal Representation

Attorney
Patrick J. Jennings

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Oct 6, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 6, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 26, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 25, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 25, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 25, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 3, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 9, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 9, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 19, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 30, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 31, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 12, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of benign prostatic hyperplasia and prostate cancer

Classification

International Classes
005